MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Dechra Pharmaceuticals plc Company Profile (LON:DPH)

Consensus Ratings for Dechra Pharmaceuticals plc (LON:DPH) (?)
Ratings Breakdown: 3 Hold Rating(s), 5 Buy Rating(s)
Consensus Rating:Buy (Score: 2.63)
Consensus Price Target: GBX 1,171.13

Analysts' Ratings History for Dechra Pharmaceuticals plc (LON:DPH)
Show:
DateFirmActionRatingPrice TargetActions
6/24/2016Numis Securities LtdReiterated RatingAddGBX 1,285View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/3/2016Jefferies GroupDowngradeHoldGBX 1,140 -> GBX 1,099View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/17/2016InvestecBoost Price TargetBuyGBX 1,152 -> GBX 1,255View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/17/2016RBC CapitalUpgradeOutperformGBX 1,080 -> GBX 1,320View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/15/2016Stifel NicolausReiterated RatingBuyGBX 1,280View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/15/2016Panmure GordonReiterated RatingBuyGBX 1,140View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/22/2016FinnCapReiterated RatingUnder ReviewView Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/23/2015N+1 SingerReiterated RatingHoldGBX 1,020View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/7/2015Shore CapitalReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 6/29/2014 forward)
Earnings History for Dechra Pharmaceuticals plc (LON:DPH)
No earnings announcements for this company have been tracked by MarketBeat.com

Earnings Estimates for Dechra Pharmaceuticals plc (LON:DPH)
No earnings estimates for this company have been tracked by MarketBeat.com

Dividend History for Dechra Pharmaceuticals plc (LON:DPH)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable DateShare
2/22/2016GBX 5.550.47%3/10/20163/10/20164/6/2016Tweet This Announcement  Share This Announcement on StockTwits
9/7/2015GBX 11.821.26%10/29/201510/29/201511/20/2015Tweet This Announcement  Share This Announcement on StockTwits
9/8/2014GBX 10.651.4%11/6/201411/6/201411/21/2014Tweet This Announcement  Share This Announcement on StockTwits
2/25/2014GBX 4.750.68%3/12/20143/12/20144/8/2014Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2013 forward)
Insider Trading History for Dechra Pharmaceuticals plc (LON:DPH)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
6/3/2016Rice,TonyInsiderBuy20,000GBX 1,141£228,200Tweet This Trade  Share This Trade on StockTwits
3/21/2016Nesmes,Anne-FrancoiseInsiderSell3,100GBX 1,208£37,448Tweet This Trade  Share This Trade on StockTwits
9/9/2015Nesmes,Anne-FrancoiseÂInsiderSell18,319GBX 940£172,198.60Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)
Latest Headlines for Dechra Pharmaceuticals plc (LON:DPH)
DateHeadline
06/29/16 03:36 PMDechra Pharmaceuticals (LON:DPH) New Price Targets - FTSE News
06/25/16 07:31 AMNumis announced (LON:DPH) Dechra Pharmaceuticals PLC, upholding its price target to GBX1,285 earlier today - Breaking Finance News
06/24/16 03:46 PMNumis announced (LON:DPH) Dechra Pharmaceuticals PLC, upholding its price target to GBX1,285 earlier today
06/23/16 07:19 AMOutstanding Analyst Ratings For Dechra Pharmaceuticals (LON:DPH) - FTSE News
06/20/16 09:53 AMDechra Pharmaceuticals (LON:DPH) Broker Price Targets - Fiscal Standard
06/14/16 03:24 PMDechra Pharmaceuticals Plc : Undervalued relative to peers, but don’t ignore the other factors -
06/06/16 03:38 AMDechra Pharmaceuticals Plc breached its 50 day moving average in a Bearish Manner : DPH-GB : June 6, 2016 -
06/03/16 09:48 PMJefferies Group Lowers Dechra Pharmaceuticals plc (DPH) to Hold - Let Me Know About This
06/03/16 12:26 PM[$$] Supermarkets in retreat on Asda war signal - [at Financial Times] - Tesco and J Sainsbury slumped on Friday after investors were given the clearest signal yet that Asda is planning to launch a supermarket price war. David Cheesewright, chief executive of Asda's parent ...
06/02/16 08:52 AMDechra Pharmaceuticals (LON:DPH) Analyst Target Changes - Share Trading News - Dechra Pharmaceuticals (LON:DPH) Analyst Target ChangesShare Trading NewsA number of investment brokers have recently updated their price targets on shares of Dechra Pharmaceuticals (LON:DPH). According to the latest broker reports outstanding on Thursday 2nd of June, ... 17/03/2016 – Dechra Pharmaceuticals had its “Buy ...and more »
05/26/16 03:42 AMDechra Pharmaceuticals Plc breached its 50 day moving average in a Bullish Manner : DPH-GB : May 26, 2016 -
05/18/16 12:33 PMShould you be buying AstraZeneca plc, Alliance Pharma plc and Dechra Pharmaceuticals plc today? - Yahoo Finance UK - Should you be buying AstraZeneca plc, Alliance Pharma plc and Dechra Pharmaceuticals plc today?Yahoo Finance UKOne of the major concerns of investors in AstraZeneca (LSE: AZN) in recent years has been its ability to pay dividends. That's because it has been subjected to a patent cliff, where a number of key drugs have come off-patent and with the company ...and more »
05/17/16 12:47 PMShould you be buying AstraZeneca plc, Alliance Pharma plc and Dechra Pharmaceuticals plc today? - Motley Fool UK - Should you be buying AstraZeneca plc, Alliance Pharma plc and Dechra Pharmaceuticals plc today?Motley Fool UKMeanwhile, Dechra Pharmaceuticals (LSE: DPH) also has upbeat growth prospects. In the current year its bottom line is forecast to rise by 6%, while growth of 18% is pencilled-in for next year. Although Dechra has a rather rich P/E ratio of 26, when ...and more »
05/13/16 06:20 AMMost Traded Stocks by Value at 15:00 - Stock Market Wire - Most Traded Stocks by Value at 15:00Stock Market Wire... traded £39,722,870 BARC Barclays PLC value of shares traded £38,721,850 ITV ITV PLC value of shares traded £37,722,202 DPH Dechra Pharmaceuticals PLC value of shares traded £37,690,279 RB. Reckitt Benckiser Group PLC value of shares traded ...and more »
05/07/16 05:57 AMDechra Pharmaclts (LON:DPH) Morning Trade Volumes - Share Trading News - Share Trading NewsDechra Pharmaclts (LON:DPH) Morning Trade VolumesShare Trading NewsDechra Pharmaceuticals PLC is a veterinary pharmaceuticals company. The Company is engaged in the development, manufacture and marketing of products for veterinarians across the world. The Company's segments include European Pharmaceuticals, ...
05/04/16 05:16 AMDechra Pharmaceuticals (LON:DPH) Broker Roundup - Share Trading News - Dechra Pharmaceuticals (LON:DPH) Broker RoundupShare Trading NewsRecently stock market analysts have updated their consensus ratings on shares of Dechra Pharmaceuticals (LON:DPH). The latest broker reports which ... Dechra Pharmaceuticals PLC is a veterinary pharmaceuticals company. The Company is engaged in ...and more »
04/28/16 06:07 AMSafeguard Scientifics Announces First Quarter 2016 Financial Results - PR Newswire (press release) - Safeguard Scientifics Announces First Quarter 2016 Financial ResultsPR Newswire (press release)Subsequent to the first quarter of 2016, Safeguard's partner company, Putney, was acquired by Dechra Holdings US Inc., a subsidiary of Dechra Pharmaceuticals Plc (LON:DPH), for $200 million in cash. Safeguard received cash proceeds of $58.2 million, ...and more »
04/28/16 06:07 AMAre Analysts Bearish Dechra Pharmaceuticals plc (LON:DPH) After Last Week? - The Post - Are Analysts Bearish Dechra Pharmaceuticals plc (LON:DPH) After Last Week?The PostOut of 8 analysts covering Dechra Pharmaceuticals PLC (LON:DPH), 7 rate it a “Buy”, 0 “Sell”, while 1 “Hold”. This means 88% are positive. Dechra Pharmaceuticals PLC has been the topic of 38 analyst reports since August 3, 2015 according to ...and more »
04/25/16 06:31 AMDechra Pharmaceuticals (LON:DPH) Analyst Target Prices - FTSE News - Dechra Pharmaceuticals (LON:DPH) Analyst Target PricesFTSE NewsRecently stock market analysts have updated their consensus ratings on shares of Dechra Pharmaceuticals (LON:DPH). The newest analyst ratings which ... Dechra Pharmaceuticals PLC is a veterinary pharmaceuticals company. The Company is engaged in ...and more »
04/22/16 12:40 PMDechra Pharmaceuticals Plc – Value Analysis (LONDON:DPH) : April 22, 2016 -
04/22/16 06:47 AMNews & Tips: Ultra Electronics, Dechra, AstraZeneca & more - Investors Chronicle - News & Tips: Ultra Electronics, Dechra, AstraZeneca & moreInvestors ChronicleVeterinary pharmaceutical group Dechra (DPH) has today announced the completion of its takeover of US companion animal company Putney Inc. The $200m deal has been funded partly by fund-raise in March and partly by extended debt facilities.
04/21/16 03:38 AMDechra Pharmaceuticals Plc breached its 50 day moving average in a Bearish Manner : DPH-GB : April 21, 2016 -
04/18/16 03:10 AMUpdate on Proposed Acquisition - [at noodls] - In order to view the materials related to the Update on the Proposed Acquisition, you must select your current country of residence below. The following material and information does not constitute an ...
04/15/16 09:56 AMDechra set to complete Putney acquisition - The expiration of the waiting period satisfies the primary condition to the closing of the proposed acquisition. At 3:09pm: (LON:DPH) Dechra Pharmaceuticals PLC share price was -4.5p at 1183.5p Story provided by StockMarketWire.com
04/13/16 12:05 PMSirius Minerals PLC (LON:SXX) Issued With 'Buy' Rating From Liberum Capital - Dechra Pharmaceuticals PLC is a veterinary pharmaceuticals company ... consists of Dechra Veterinary Products EU and Dechra Pharmaceuticals Manufacturing; North American (LON:DPH) Pharmaceuticals, consists of Dechra Veterinary Products US and Dechra ...
04/11/16 12:57 PMAre Analysts Bullish Dechra Pharmaceuticals plc (LON:DPH) After Last Week? - Stock Caller - Are Analysts Bullish Dechra Pharmaceuticals plc (LON:DPH) After Last Week?Stock CallerOut of 8 analysts covering Dechra Pharmaceuticals PLC (LON:DPH), 7 rate it “Buy”, 0 “Sell”, while 1 “Hold”. This means 88% are positive. Dechra Pharmaceuticals PLC was the topic in 38 analyst reports since August 3, 2015 according to StockzIntelligence ...and more »
04/07/16 10:24 AMToday Dechra Pharmaceuticals plc Stock Reaches 52-Week High - Stock Caller - Share Trading NewsToday Dechra Pharmaceuticals plc Stock Reaches 52-Week HighStock CallerThe stock of Dechra Pharmaceuticals plc (LON:DPH) hit a new 52-week high and has GBX 1897.20 target or 53.00% above today's GBX 1240.00 share price. The 6 months bullish chart indicates low risk for the GBX 1.15B company. The 1-year high was ...What's in Dechra Pharmaceuticals plc After Reaching All-Time High?Business Standard Tribuneall 5 news articles »
03/21/16 09:53 AMFTSE 250 movers: Synthomer gains on acquisition; Halfords and N Brown slump -
03/18/16 11:01 AMDirector Deals - Dechra Pharmaceuticals PLC (DPH) - StockMarketWire.com - Ian Page, Chief Executive Officer, sold post-exercise 41,440 shares in the company on the 17th March 2016 at a price of 1210.00p. The Director now holds 752,166 shares. NOTE: Sold to cover tax liabilities etc.
03/17/16 10:58 AMAnalysts At Cantor Fitzgerald Reiterated Dechra Pharmaceuticals PLC (LON:DPH) As Buy - Risers & Fallers - Analysts At Cantor Fitzgerald Reiterated Dechra Pharmaceuticals PLC (LON:DPH) As BuyRisers & FallersToday analysts at Cantor Fitzgerald reiterated Dechra Pharmaceuticals PLC's (LON:DPH) shares as 'Buy' in a report released to investors. According to Cantor Fitzgeralds price target of 1300 on the company's stock this indicates the broker now believes ...
03/17/16 10:58 AMDechra Pharmaceuticals plc (DPH) Upgraded by Numis Securities Ltd to “Add” - MicroCap Magazine - Business Standard TribuneDechra Pharmaceuticals plc (DPH) Upgraded by Numis Securities Ltd to “Add”MicroCap MagazineDechra Pharmaceuticals plc logo Dechra Pharmaceuticals plc (LON:DPH) was upgraded by equities research analysts at Numis Securities Ltd to an “add” rating in a research note issued on Thursday, Marketbeat.com reports. The firm currently has a GBX ...Dechra Pharmaceuticals plc (DPH) Lifted to "Outperform" at RBC CapitalThe Vista VoiceInvestec Boosts Dechra Pharmaceuticals plc (DPH) Price Target to GBX 1255The Hilltop NewsDechra Pharmaceuticals PLC (LON:DPH) Receives Outperform Rating From RBC Capital Markets AnalystsRisers & FallersBusiness Standard Tribune -OctaFinance.comall 67 news articles »
03/15/16 08:41 PMAnalysts At Cantor Fitzgerald Reiterated Dechra Pharmaceuticals PLC (LON:DPH) As Buy - Dechra is an global specialist veterinary pharmaceuticals and related products business. They presently have a GBX 1,095 ($15.67) price objective on the stock. Numis Securities Ltd's price target points to a potential downside of 6.09% from the company's ...
03/15/16 05:22 PMPortland pet pharmaceutical company bought for $200M -
03/15/16 10:08 AMDechra Pharm PLC (DPH) - Proposed £48.4 million Placing of New Ordinary Shares at 1100 pence per share Dechra Pharmaceuticals PLC announces the conditional acquisition of the entire share capital of Putney, Inc, a leading developer of generic companion animal pharmaceuticals in ...
03/15/16 05:38 AMDechra Pharmaceuticals PLC, Agrees Acquisition of US-based Putney, Inc for $200 Million -
03/15/16 03:15 AMDechra to gobble up Putney in £140m deal -
03/01/16 12:36 PMCantor Fitzgerald Starts Coverage on Dechra Pharmaceuticals PLC (LON:DPH) with "Buy" and with GBX 1300.00 Target - OctaFinance.com - Cantor Fitzgerald Starts Coverage on Dechra Pharmaceuticals PLC (LON:DPH) with "Buy" and with GBX 1300.00 TargetOctaFinance.comThe financial firm Cantor Fitzgerald has initiated coverage on Dechra Pharmaceuticals PLC (LON:DPH)'s stock, rating it “Buy” while setting the TP at GBX 1300.00. After the initiation LON:DPH is now trading -0.84% lower at GBX 1175.00 as of 16:12 London ...and more »
02/27/16 11:57 AMAnalysts At Cantor Fitzgerald Indicated Dechra Pharmaceuticals PLC (LON:DPH) As Buy - Risers & Fallers - Franklin IndependentAnalysts At Cantor Fitzgerald Indicated Dechra Pharmaceuticals PLC (LON:DPH) As BuyRisers & FallersToday analysts at Cantor Fitzgerald indicated Dechra Pharmaceuticals PLC's (LON:DPH) shares as 'Buy' in a report released to investors. According to Cantor Fitzgeralds price target of 1300 on the company's stock this indicates the broker now believes ...Dechra Pharmaceuticals PLC (LON:DPH) Hit With Buy Rating At Cantor Fitzgerald, Firm Sees GBX 1300.00 Stock PriceFranklin Independentall 5 news articles »
02/25/16 10:31 AMLondon midday: RSA and Lloyds lead rally in equities -
02/23/16 03:12 PMDechra Pharmaceuticals Plc : Fairly valued, but don’t skip the other factors -
02/22/16 06:23 PMShould You Buy Dechra Pharmaceuticals plc, Enquest Plc & Cairn Energy PLC Today? - The Motley Fool UK - Should You Buy Dechra Pharmaceuticals plc, Enquest Plc & Cairn Energy PLC Today?The Motley Fool UKPet medicines mammoth Dechra Pharmaceuticals (LSE: DPH) cheered the market with terrific half-year numbers in Monday business, propelling the stock 8% higher from the end of last week. Dechra advised that group revenues surged 9.7% between July ...and more »
02/22/16 11:41 AMDechra has strong H1 - We remain in a strong position to continue to grow the business and deliver returns to our shareholders." At 9:26am: (LON:DPH) Dechra Pharmaceuticals PLC share price was +76p at 1138p Story provided by StockMarketWire.com
02/22/16 10:27 AMDechra's sales take off after poultry acquisition -
02/22/16 06:40 AMShould You Buy Dechra Pharmaceuticals plc, Enquest Plc & Cairn Energy PLC Today? -
02/22/16 06:07 AMHalf Year 2016 Dechra Pharmaceuticals PLC Earnings Release - Before Market Open -
02/22/16 02:37 AMDechra Pharmaceuticals PLC: Half-Yearly Financial Report 2016 - - Trading in our first half was strong with Group revenue growth, including Genera, of 14.9% at Constant Exchange Rate (CER) (9.7% at Actual Exchange Rate (AER)) and underlying operating profit growth of 24.2% at CER (13.9% at AER). - Excluding Genera ...
02/22/16 02:13 AMExchange rate headwinds prevail at Dechra -
02/19/16 03:31 AMDechra Pharmaceuticals Plc breached its 50 day moving average in a Bullish Manner : February 19, 2016 -
02/16/16 10:57 AMMerlin names Anne-Françoise Nesmes as new CFO - MarketWatch - DIGITALLOOKMerlin names Anne-Françoise Nesmes as new CFOMarketWatchShe is currently chief financial officer of Dechra Pharmaceuticals PLC (DPH.LN), a FTSE 250 veterinary pharmaceuticals company. Dechra PharmMerlin Entertainments PLC (MERL.LN) aceuticals said it has commenced the process to recruit a replacement.Merlin Entertainments appoints Dechra CFO Anne-Françoise Nesmes as CFORTT Newsall 15 news articles »
02/16/16 10:57 AMMerlin Entertainments Appoints Dechra CFO Anne-Françoise Nesmes As CFO - Nesmes is currently Chief Financial Officer and Executive Director of Dechra Pharmaceuticals plc (DPH.L), where she has held the role since April 2013. Previously she worked for GlaxoSmithKline (GSK) in a number of senior finance roles. Meanwhile ...
About Dechra Pharmaceuticals plc

Dechra Pharmaceuticals plc logoDechra Pharmaceuticals PLC is a veterinary pharmaceuticals company. The Company is engaged in the development, manufacture and marketing of products for veterinarians across the world. The Company's segments include European Pharmaceuticals, consists of Dechra Veterinary Products EU and Dechra Pharmaceuticals Manufacturing; North American (NA) Pharmaceuticals, consists of Dechra Veterinary Products US and Dechra Veterinary Products Canada, and Pharmaceuticals Research and Development. The European Pharmaceuticals segment manufactures and markets companion animal, equine and food producing animal products. The North American (NA) Pharmaceuticals segment sells companion animal and equine products. The Pharmaceuticals Research and Development Segment include all of the Company's pharmaceutical research and development activities. Its products include Vetoryl, Felimazole, Isaderm, CleanAural, Sedator, Lubrithal, Equipalazone, Rapidexon, Soludox and Atipam, among others.

Industry, Sector and Symbol:
  • Sector: N/A
  • Industry: N/A
  • Sub-Industry: N/A
  • Exchange: LON
  • Symbol: DPH
  • CUSIP:
Key Metrics:
  • Previous Close: $15.10
  • 50 Day Moving Average: $1107.62
  • 200 Day Moving Average: $1106.48
  • P/E Ratio: 49.78
  • P/E Growth: 1.53
  • Market Cap: $1061.62B
  • Current Quarter EPS Consensus Estimate: $42.32 EPS
Additional Links:

            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha